Israel Englander Bristol Myers Squibb CO Call Options Transaction History

Millennium Management LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$39.66 - $51.75 $3.3 Million - $4.3 Million	83,100 Added 13.61%	693,800 $35.9 Million
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $784,875 - $1.03 Million	19,500 Added 3.3%	610,700 $25.4 Million
Q1 2024 May 15, 2024	SELL	$47.98 - $54.4 $7.95 Million - $9.01 Million	-165,700 Reduced 21.89%	591,200 $32.1 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $13 Million - $15.5 Million	-267,200 Reduced 26.09%	756,900 $38.8 Million
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $66.8 Million - $74.2 Million	-1,048,400 Reduced 50.59%	1,024,100 $65.5 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $39.1 Million - $44.4 Million	-595,400 Reduced 22.32%	2,072,500 $144 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $80.2 Million - $94.9 Million	1,170,500 Added 78.17%	2,667,900 $192 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $86,138 - $50.9 Million	662,600 Added 79.37%	1,497,400 $106 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.